Coforge
Coforge reported a revenue beat, with constant currency revenue growth of 4.4%, ahead of estimates of 3.5%. The order book grew 30% year-on-year.
EBIT margin was largely in line with expectations at 13.4% versus an estimated 13.2%.
However, profit after tax declined sharply to ₹250.2 crore from ₹376 crore in the previous quarter, impacted by an exceptional loss of ₹147.6 crore.
This was primarily due to higher labour wage costs of ₹117.9 crore, cybersecurity-related expenses of ₹16.2 crore and acquisition-related costs of ₹13.5 crore related to the Encora deal.
Mphasis
Mphasis delivered a largely in-line performance for the quarter, with CC revenue growth of 1.5%, matching estimates. EBIT margin stood at 15.2%, marginally ahead of expectations.
New deal total contract value came in at $428 million, down about 19% sequentially but up 22% year-on-year, while trailing twelve-month deal wins doubled from a year ago.
Growth was led by the BFSI segment, which expanded 3.7% sequentially, with insurance growing 8.3%. In contrast, TMT, logistics and other verticals saw a decline.
Geographically, India and EMEA led growth, while the Americas posted modest gains.
Management said the March quarter is expected to be the strongest sequentially, led by deal ramp-ups, and reiterated that FY26 growth will be meaningfully better than FY25, with momentum likely to continue into FY27.
Brokerage firm Nomura has maintained a 'Neutral' rating on Mphasis with a price target of ₹2,970, citing stable margins and a strong AI-driven deal pipeline.
HSBC has reiterated its 'Buy' rating with a price target of ₹3,350. The brokerage said that while deal wins moderated marginally in Q3, the pipeline remains robust and overall revenue momentum is intact.
Supported by steady deal inflows and a favourable banking sector backdrop, HSBC expects Mphasis to deliver nearly double-digit revenue growth over the next two years, adding that valuations remain relatively undemanding with an attractive risk-reward profile.
Jefferies also has a 'Buy' rating, with a price target of ₹3,410. The brokerage said Mphasis' Q3 revenues were in line, while margins and normalised profits were slightly ahead.
Jefferies expects growth to accelerate to a 10% YoY CC CAGR over FY26-28, driven by strong deal wins, a large pipeline and healthy growth prospects in the BFSI segment.
It has trimmed FY26-28 earnings estimates by up to 1.5% to factor in higher interest costs, while forecasting a 14% EPS CAGR over the same period.
Zensar Technologies
Zensar Technologies reported a margin-led beat, even as revenue growth remained weak. Constant currency revenue declined 1.3% sequentially, reflecting softness in demand. However, EBITDA margin expanded sharply to around 17.4% from 15.5% in the previous quarter, aided by higher offshore mix and operational efficiencies. The company said nearly 20% of its current order book is AI-influenced, signalling its transition towards an AI-native services model.
Cigniti Technologies
Cigniti Technologies delivered a strong operational performance in the December quarter, with growth across revenue, profitability and margins. Consolidated net profit rose to ₹80 crore from ₹63.6 crore a year ago, while revenue increased to ₹580 crore from ₹510 crore.
EBITDA climbed to ₹115 crore from ₹90.3 crore, with margins improving to nearly 20%, reflecting better cost control and operating leverage.
/images/ppid_59c68470-image-176913753268037775.webp)

/images/ppid_a911dc6a-image-176913522973130302.webp)
/images/ppid_59c68470-image-176913512351082622.webp)
/images/ppid_59c68470-image-176913502980497729.webp)
/images/ppid_59c68470-image-176913505878041850.webp)
/images/ppid_59c68470-image-176913509018012090.webp)
/images/ppid_a911dc6a-image-17691345389138312.webp)
/images/ppid_59c68470-image-176913256921227374.webp)
/images/ppid_59c68470-image-176913263516396562.webp)
/images/ppid_59c68470-image-176913253056075494.webp)
/images/ppid_59c68470-image-176913260070755812.webp)